Scope Fluidics SA GPW:SCP:
FY NET LOSS AT 46.4 MILLION ZLOTYS
FY 2025 REVENUE 100,000 ZLOTYS
Scope Fluidics FY Net Loss At 46.4 Million Zlotys
Story so far
Earlier from Scope Fluidics
- Scope Fluidics Updates Objectives For Bacteromic Project For 2026-2027
- Scope Fluidics Obtains CE-IVDR Certification For Bacteromic System
- Scope Fluidics Unit Adopts Plan For Production Readiness For Bacteromic System Panels
- Scope Fluidics Unit Signs Framework Distribution Deal With SC Elta 90 Medical Research
- Scope Fluidics Signs Distribution Deal For Bacteromic System In Turkey
Later from Scope Fluidics
- Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
- Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
- Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
- Scope Fluidics Says Bacteromic Buys New Location For Semi-Automated Bacteromic Panel Production Line
- Scope Fluidics' Bacteromic Signs Agreement With Comac Medical For Clinical Trials Of Bacteromic PBC Panel
Follow Scope Fluidics into a list and get an email when it puts out news.
Follow Scope Fluidics